Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
Questions & Answers from the AHA 2023 Symposium
Questions & Answers from the AHA 2023 Symposium